Pyrrosia lingua for Health & Longevity - Quick Reference Sheet

Pyrrosia lingua for Health & Longevity

Created on 06/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

An East Asian traditional leaf remedy (Shi Wei) used for urinary complaints and kidney stones. Laboratory and animal work suggests free-radical scavenging, reduced kidney-stone formation, and an early bone-protection signal, but no human trials, safety testing, or agreed dose exist. The most grounded possibilities are kidney-stone prevention and antioxidant activity, both still uncertain. (Full Review)

Protocol

Traditional Decoction
~6–12 g/day dried leaf
Water decoction, often combined in a formula; traditional practice, not a validated regimen
Dosing Schedule
Split, daytime
Divided into two daily portions; daytime dosing to avoid nocturnal urination
Form
Whole-leaf vs. extract
Extract is not simply a stronger decoction; neither approach established as superior
Time to effect
Stone Prevention / Bone
Weeks to months
If real, would require sustained use; no human time-course data exist
Urinary Symptoms
Within days
Expected within days of starting a decoction for the traditional urinary uses

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Significant kidney impairment
  • Children
  • Narrow-therapeutic-index medications without clinical supervision
Key Interactions
  • Fluoroquinolone antibiotics (levofloxacin)
  • CYP-metabolized drugs (via quercetin, kaempferol)
  • NSAIDs (ibuprofen)
  • Flavonoid/polyphenol supplements (quercetin, green-tea catechins)
  • Stone-prevention supplements (potassium citrate, magnesium)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Unknown human safety profile / lack of toxicology data; heavy-metal and contaminant accumulation
  • Speculative: Gastrointestinal upset; species-substitution and misidentification harm; theoretical risk in pregnancy and "yin-deficiency" states

Monitoring

Marker Target Why
eGFR >90 mL/min/1.73 m² Confirms kidney filtering capacity is preserved while using a urinary-active herb
Serum creatinine 0.7–1.1 mg/dL Detects any decline in kidney function
24-hour urinary oxalate <30 mg/24 h Tracks the main driver of calcium-oxalate stones, the herb's traditional target
24-hour urinary citrate >320 mg/24 h Higher citrate inhibits stone formation; gauges overall stone risk context
Heavy metals (cadmium, lead) Below reference limits Flags contaminant exposure from a metal-accumulating fern

Cadence: Baseline, then a short follow-up at ~4–8 weeks, then every 6–12 months for long-term use

Qualitative Assessment

  • Urinary symptoms (frequency, urgency, discomfort, or episodes of stone passage)
  • General digestive tolerance (nausea or stomach discomfort)
  • Overall energy and well-being (non-specific)